|
|
Click-Crosslinked Injectable Gelatin Hydrogels
Amrathlal Rabbind Singh
,
Philippe Lacan
,
Estelle Cadet
,
Patricia Bignet
,
Cécile Dumesnil
et al.
Journal articles
hal-02467955v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A
Sandra Bodeau
,
Chloé Sauzay
,
Remy Nyga
,
Christophe Louandre
,
Veronique Descamps
et al.
Journal articles
hal-03574261v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway
Hiba Abou Daya
,
Sana Kouba
,
Hakim Ouled-Haddou
,
Nazim Benzerdjeb
,
Marie-Sophie Telliez
et al.
Journal articles
hal-03605606v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A New Intergenic α -Globin Deletion ( α – α Δ125 ) Found in a Kabyle Population
Amrathlal Rabbind Singh
,
Philippe Lacan
,
Estelle Cadet
,
Patricia Bignet
,
Cécile Dumesnil
et al.
Journal articles
hal-02330579v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Randomised Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS or Low Blast AML: GFM's "Pick a Winner" Trial, with the Impact of Somatic Mutations
Lionel Adès
,
Nicolas Duployez
,
Agnes Guerci-Bresler
,
Kamel Laribi
,
Pierre Peterlin
et al.
Journal articles
hal-03740498v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
Maël Heiblig
,
Nicolas Duployez
,
Alice Marceau
,
Delphine Lebon
,
Laure Goursaud
et al.
Journal articles
hal-03606389v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
Emmanuel Bachy
,
Roch Houot
,
Pierre Feugier
,
Krimo Bouabdallah
,
Reda Bouabdallah
et al.
Journal articles
hal-03679319v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RAR alpha Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
Eytan M. Stein
,
Stephane de Botton
,
Thomas Cluzeau
,
Arnaud Pigneux
,
Jane L. Liesveld
et al.
Journal articles
hal-03606393v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively
Reinaldo Dal Bello
,
Kim Pacchiardi
,
Clémentine Chauvel
,
Lionel Adès
,
Thorsten Braun
et al.
Journal articles
hal-03915538v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
EVOLUTION OF REGULATORY B CELLS UNDER TREATMENT BY BIOLOGICS IN RHEUMATOID ARTHRITIS
S. Salomon
,
C. Guignant
,
C. Brault
,
G. Flahaut
,
B. Gubler
et al.
Journal articles
hal-03564087v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
Mohamad Mohty
,
Ibrahim Yakoub-Agha
,
Myriam Labopin
,
Didier Blaise
,
Delphine Lebon
et al.
Journal articles
hal-03606392v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|